inhibitor

(redirected from Neuraminidase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Neuraminidase inhibitor: Oseltamivir, amantadine, Tamiflu, Zanamivir
See: deterrent
References in periodicals archive ?
Treatment with neuraminidase inhibitors shortens the course of influenza among children, but physicians should look for more compelling reasons to use this treatment in specific patents, Dr.
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
Studies are still needed to test whether neuraminidase inhibitors actually reduce mortality, whether they have any therapeutic impact on primary viral pneumonia or other severe influenza virus complications, and how they can be used in hospitalized patients, Dr.
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.
Two classes of medications are available to treat influenza: neuraminidase inhibitors (NIs), which include oseltamivir and zanamivir, and adamantanes, which include amantadine and rimantadine (2).
There is no direct evidence that neuraminidase inhibitor treatment reduces serious sequelae of the flu, but "encouraging" preliminary evidence suggests that treatment with Relenza or the Roche product reduces the rates of secondary complications, added Dr.
Vaccination or chemoprophylaxis of contacts is infrequently addressed, mainly because the vaccine supply is limited, as are the most effective antiviral drugs, the neuraminidase inhibitors oseltamivir and zanamivir, for the next several years.
Zanamivir, the first in a new class of antivirals known as neuraminidase inhibitors, is now under FDA review for marketing approval.
Inavir([R]) (laninamivir octanoate) is the first of a new class of long acting neuraminidase inhibitors (LANIs) designed to address the limitation of the current influenza anti-virals, which require daily or more frequent dosing.
Use of the selective oral neuraminidase inhibitor to prevent influenza.
Peramivir is an intravenous (IV) viral neuraminidase inhibitor that is used for the treatment of influenza in patients who are over 18 and have exhibited symptoms for no more than two days.